Strengthening Africa's response to Mpox (monkeypox): insights from historical outbreaks and the present global spread

David B. Olawade , Ojima Z. Wada , Sandra Chinaza Fidelis , Oluwafemi S. Oluwole , Chibuike S. Alisi , Nifemi F. Orimabuyaku , Aanuoluwapo Clement David-Olawade
{"title":"Strengthening Africa's response to Mpox (monkeypox): insights from historical outbreaks and the present global spread","authors":"David B. Olawade ,&nbsp;Ojima Z. Wada ,&nbsp;Sandra Chinaza Fidelis ,&nbsp;Oluwafemi S. Oluwole ,&nbsp;Chibuike S. Alisi ,&nbsp;Nifemi F. Orimabuyaku ,&nbsp;Aanuoluwapo Clement David-Olawade","doi":"10.1016/j.soh.2024.100085","DOIUrl":null,"url":null,"abstract":"<div><div>Mpox, formerly known as Monkeypox, is a viral zoonotic disease endemic to Central and West Africa that has posed significant public health challenges since its identification in 1970. Despite decades of experience in managing outbreaks, the 2022–2024 Mpox outbreaks exposed substantial gaps in global preparedness and response, leading the World Health Organization (WHO) to declare a Public Health Emergency of International Concern (PHEIC) in 2022. The resurgence of cases in Europe in 2022 and the more recent emergence of the virulent clade Ⅰb in the Democratic Republic of the Congo (DRC) in 2024 have highlighted a critical need for improved proactive and response strategies to curb the epidemic. This narrative review examines the historical and recent epidemiology of Mpox in Africa and explores the factors that have limited effective management. These include objective influences such as viral mutations, zoonotic transmission patterns, and environmental changes like deforestation, as well as subjective factors, including delayed responses, limited vaccine availability, cessation of smallpox vaccinations, and inequitable access to healthcare. In particular, the review emphasizes the ongoing disparities in global health equity, as wealthier nations have been able to secure vaccines and therapeutics quickly, while endemic regions in Africa continue to struggle with limited resources. The review also discusses how socio-economic and cultural factors, combined with weak public health infrastructure and inadequate surveillance systems, perpetuate cycles of outbreak in vulnerable populations. Furthermore, the emergence of clade Ⅰb in 2024, with its higher virulence and mortality rates among children, particularly in rural areas, underscores the urgency of addressing the evolving epidemiological landscape of Mpox. In response to these challenges, this review recommends strengthening healthcare infrastructure, enhancing surveillance systems, ensuring equitable access to vaccines and treatments, and integrating environmental management into public health strategies. Global collaboration remains essential to provide African countries with the resources and support needed to manage and prevent future outbreaks effectively. Without these measures, the world risks a prolonged public health crisis with far-reaching consequences for both Africa and the global community.</div></div>","PeriodicalId":101146,"journal":{"name":"Science in One Health","volume":"3 ","pages":"Article 100085"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science in One Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949704324000246","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Mpox, formerly known as Monkeypox, is a viral zoonotic disease endemic to Central and West Africa that has posed significant public health challenges since its identification in 1970. Despite decades of experience in managing outbreaks, the 2022–2024 Mpox outbreaks exposed substantial gaps in global preparedness and response, leading the World Health Organization (WHO) to declare a Public Health Emergency of International Concern (PHEIC) in 2022. The resurgence of cases in Europe in 2022 and the more recent emergence of the virulent clade Ⅰb in the Democratic Republic of the Congo (DRC) in 2024 have highlighted a critical need for improved proactive and response strategies to curb the epidemic. This narrative review examines the historical and recent epidemiology of Mpox in Africa and explores the factors that have limited effective management. These include objective influences such as viral mutations, zoonotic transmission patterns, and environmental changes like deforestation, as well as subjective factors, including delayed responses, limited vaccine availability, cessation of smallpox vaccinations, and inequitable access to healthcare. In particular, the review emphasizes the ongoing disparities in global health equity, as wealthier nations have been able to secure vaccines and therapeutics quickly, while endemic regions in Africa continue to struggle with limited resources. The review also discusses how socio-economic and cultural factors, combined with weak public health infrastructure and inadequate surveillance systems, perpetuate cycles of outbreak in vulnerable populations. Furthermore, the emergence of clade Ⅰb in 2024, with its higher virulence and mortality rates among children, particularly in rural areas, underscores the urgency of addressing the evolving epidemiological landscape of Mpox. In response to these challenges, this review recommends strengthening healthcare infrastructure, enhancing surveillance systems, ensuring equitable access to vaccines and treatments, and integrating environmental management into public health strategies. Global collaboration remains essential to provide African countries with the resources and support needed to manage and prevent future outbreaks effectively. Without these measures, the world risks a prolonged public health crisis with far-reaching consequences for both Africa and the global community.
加强非洲对猴痘的应对:从历史疫情和目前的全球传播中得到的启示
天花(原名猴痘)是一种流行于非洲中部和西部的病毒性人畜共患病,自1970年被确认以来一直对公共卫生构成重大挑战。尽管已有数十年管理疫情的经验,但 2022-2024 年爆发的天花疫情暴露了全球防备和应对工作的巨大差距,导致世界卫生组织(WHO)于 2022 年宣布将其列为国际关注的突发公共卫生事件(PHEIC)。2022年欧洲再次出现病例,最近2024年刚果民主共和国(DRC)又出现了毒力更强的Ⅰb支系,这些都凸显出亟需改进预防和应对策略以遏制疫情。这篇叙述性综述研究了非洲麻风腮的历史和近期流行病学,并探讨了限制有效管理的因素。这些因素包括病毒变异、人畜共患病传播模式、森林砍伐等环境变化等客观影响因素,也包括反应迟缓、疫苗供应有限、停止天花疫苗接种、医疗服务不公平等主观因素。综述特别强调了全球卫生公平性方面持续存在的差距,因为富裕国家能够迅速获得疫苗和治疗方法,而非洲流行地区则继续在有限的资源中挣扎。综述还讨论了社会经济和文化因素如何与薄弱的公共卫生基础设施和不完善的监测系统相结合,使易感人群中的疫情循环往复。此外,Ⅰb 支系将于 2024 年出现,其毒性更强,儿童死亡率更高,尤其是在农村地区。为应对这些挑战,本综述建议加强医疗保健基础设施,强化监测系统,确保公平获得疫苗和治疗,并将环境管理纳入公共卫生战略。全球合作对于为非洲国家提供有效管理和预防未来疫情爆发所需的资源和支持仍然至关重要。如果不采取这些措施,世界将面临长期的公共卫生危机,给非洲和全球社会带来深远影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信